CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Phone+1-800-6848880
Debt
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / BookN/A
Profitability
Net IncomeN/A
Net MarginsN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
OptionableNot Optionable
CareFusion (NYSE:CFN) Frequently Asked Questions
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) posted its earnings results on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.20. The healthcare company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.01 billion. CareFusion's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the firm earned $0.54 earnings per share. View CareFusion's Earnings History.
Has CareFusion been receiving favorable news coverage?
News stories about CFN stock have trended very negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. CareFusion earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned media stories about the healthcare company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the near future.
What is CareFusion's official website?
How can I contact CareFusion?
CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.
MarketBeat Community Rating for CareFusion (NYSE CFN)
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.
